Giant Eagle now offers 10 free antibiotics at its 210 pharmacies
By Kim Leonard
Published: Thursday, Sept. 3, 2009
First, it was $4 prescriptions. Now Giant Eagle stores plan to make 10 commonly prescribed antibiotics available free at their pharmacies as a way to build customer loyalty.
O'Hara-based Giant Eagle Inc. said the program that should ease many families' worries over prescription drug prices will begin today at all 210 pharmacies that operate inside Giant Eagle supermarkets.
The no-cost antibiotics program should save customers $4.6 million a year, said Randy Heiser, vice president of pharmacy.
"This is a program that can help a lot of consumers," Heiser said Wednesday. "This time of year, as kids go back to school and people spend more time indoors, certain infections become prevalent."
For Giant Eagle, the idea is to pull in customers who need other prescription medicines, in addition to an antibiotic. "If we attract enough customers, there would be sufficient new business to make this benefit the company in the long run," he said.
The drugs, available in 46 dosages, are Amoxicillin, Ampicillin, Cephalexin, Ciprofloxacin, Doxycycline Hyclate, Erythromycin, Penicillin, Sulfamethoxazole/Trimethoprim, Tetracycline and Bacitracin.
Doctors prescribe them as "first-line medications" to start treating a variety of ailments from strep throat and ear infections to pneumonia, acne and urinary tract infections, moving to stronger drugs if needed, Heiser said.
In most cases, the course of treatment for an antibiotic is 10 to 15 days, he said.
Following moves by Wal-Mart and Target, Giant Eagle began pricing generic versions of many commonly sold prescription drugs at $4 in November 2006. That program, gradually expanded to around 400 drugs, adds up to $64 million in savings to customers each year, the company said.
All of Giant Eagle's now-free antibiotics were on the $4 list before, Heiser said.
Giant Eagle got into the pharmacy business in March 1980, and this past fiscal year it hit a "significant milestone" of $1 billion in sales, Heiser said. Total revenue for the company was $8.2 billion.
Prescription counters now operate in 210 of the 220 supermarkets Giant Eagle operates in Pennsylvania, Ohio, West Virginia and Maryland.
Giant Eagle isn't the first grocer to offer no-cost prescriptions. Publix supermarkets in Florida, Schnucks in Missouri and Wegmans, based in Rochester, N.Y., with stores in several Pennsylvania markets, have run similar initiatives.
But the region's largest grocery chain appears to be the first in the Pittsburgh area to try it. And its 10-drug program appears to reach further than other chains' prescription giveaways, said Bill Bishop, chairman of retail consulting firm Willard Bishop LLC of Barrington, Ill.
"Giant Eagle has been a leader in this regard, in terms of being in the front of the parade in recognizing new connections that influence grocery shoppers," Bishop said, citing the chain's fuelperks! and other promotions.
Retail analyst Burt P. Flickinger III said Giant Eagle's program is well-timed now that many cash- and credit-constrained shoppers are saving up for the flu shots their families will need this fall.
Giving them a break on antibiotics will be a big help, he said. Also, Giant Eagle has watched dominant chains in some markets outside Pittsburgh where it does business use free antibiotic programs successfully.
Drug store chains CVS, Walgreens and Rite Aid have responded to supermarkets' initiatives by lowering prices on prescription refills, Flickinger said.
Giant Eagle's free antibiotics plan has one more notable perk, primarily for younger patients.
Special flavorings to help the medicine go down normally cost $3.99 at Giant Eagle pharmacies, or $2.99 for customers with Advantage cards. But they'll be added free to liquid antibiotics in the new program.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Western Pennsylvania engineer aboard missing Malaysian Airlines flight, employer says
- Analysis: Kesler still on Pens’ radar as Shero aims to bring back ‘Big 3’
- Pirates notebook: Volquez, Morton struggle
- Original tea partyers returning to GOP fold
- Starkey: Steelers know when to say goodbye
- Experts: Anti-vaccine view a peril
- ‘Un-American’? That’s Harry Reid, the Senate’s lowly smear artist
- Penguins GM Shero’s deadline deals: Addition by subtraction
- 2 dozen injured as California school stage falls
- How to find a child therapist
- Pirates’ big risk with pitch-heavy draft focus might soon pay off